Skip to main content
    K

    Korro Bio, Inc. (KRRO)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $12.71
    -0.90 (-6.61%)

    Market Cap: $186.81M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    59%(17/29)
    Avg Surprise
    -71.63%
    Streak
    5 Q

    Upcoming Estimates

    Reports Mar 10, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$1.38
    Range-$2.39 - -$0.62
    14 analysts
    Revenue Consensus
    $2.19M
    RangeN/A
    12 analysts
    Reports May 5, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$1.03
    Range-$1.25 - -$0.80
    6 analysts
    EPS Revisions
    2
    0
    30d
    EPS Estimate DriftChange to current
    90d ago-$1.04+1.5%
    60d ago-$1.04+1.5%
    30d ago-$1.04+1.5%
    7d ago-$1.04+1.5%
    Current-$1.03
    Revenue Consensus
    $125.00K
    RangeN/A
    4 analysts

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCF-3.56xFCF Yield-28.13%
    Profitability
    Profit Margin0.00%Operating Margin-5891.00%
    ROE-113.30%ROIC-82.82%
    Financial Health
    Debt/Equity0.44xInterest CoverageN/A
    Current Ratio7.30xQuick Ratio7.30x
    Trading Statistics
    Beta2.07Avg Volume221.80K
    52-Week High$17.3552-Week Low$5.20

    Technical Indicators Dashboard

    As of Nov 16, 2026, the price is 7.1% above its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 47.1, in the neutral range between 30 and 70.

    Moving Averages

    SMA 10$14.77
    SMA 20$13.70
    SMA 50$11.87
    SMA 200$12.16
    EMA 10$14.09
    EMA 20$13.57
    EMA 50$12.57
    EMA 200$12.98

    MACD

    Line: 0.79Signal: 1.03Hist: -0.23

    ADX

    ADX: 22.9+DI: 20.8-DI: 28.0

    Aroon & PSAR

    Aroon Up64.0
    Aroon Down8.0
    PSAR$16.58

    Bollinger Bands

    Upper Band$17.66
    Lower Band$9.74
    %B Position5779%(Upper)
    Band Width0.38

    RSI (14-Day)

    Neutral
    47.1

    Momentum Oscillators

    Stoch %K34.9
    Stoch %D46.7
    Williams %R-79.3
    ROC (10d)-19.8%
    Momentum-3.13
    CCI (20d)-26.8
    MFI (14d)67.5

    Volatility Measures

    ATR (14d)$1.32(10.4%)
    StdDev (20d)1.98
    Hist Vol136.4%(High)

    Volume Flow

    VWAP$12.99
    OBV525.6K
    AD Line-3.9M
    CMF (20d)0.195

    Volume Metrics

    Avg Vol (20d)226.1K
    Vol Ratio0.4x(Low)
    VWMA (20d)$13.82

    Pivot Points

    R3$15.22
    R2$14.73
    R1$14.17
    Pivot Point$13.68
    S1$13.12
    S2$12.63
    S3$12.07

    Advanced Oscillators

    TSI19.46
    Ultimate Osc42.1
    KST463.76

    Financial Performance

    Related GNG Research

    No research available

    Be the first to write about KRRO

    News

    KRRO Valuation

    GNG's valuation label for KRRO is Fairly valued.

    P/FCF
    -3.6x
    P/B
    2.6x
    All KRRO metrics

    KRRO Profitability: Margins, ROIC and FCF

    Korro Bio (KRRO) has an operating margin of -5891.0% and a net margin of 0.0%. It posts -82.8% ROIC and a -4943.8% FCF margin.

    Operating margin
    -5891.0%
    Net margin
    0.0%
    ROIC
    -82.8%
    ROE
    -113.3%
    FCF margin
    -4943.8%
    FCF yield
    -28.1%
    KRRO financial statements

    Korro Bio Competitors

    The companies most similar to Korro Bio (KRRO) include Rocket Pharmaceuticals, ProQR Therapeutics BV and Precision BioSciences.

    Sector: Healthcare

    Companies most similar to Korro Bio

    KRRO Analyst Ratings

    Korro Bio (KRRO) has a Buy consensus from 11 analysts: 10 Buy or Strong Buy, 1 Hold and 0 Sell or Strong Sell.

    Consensus
    Buy
    Analysts
    11
    Strong Buy
    2
    Buy
    8
    Hold
    1
    Sell
    0
    Strong Sell
    0
    KRRO stock forecast

    KRRO Bull Case vs Bear Case

    Bull case

    • KRRO beat EPS estimates in 87.5% of its last 8 reported quarters.
    • 90.9% of KRRO's analyst ratings are Buy or Strong Buy.

    Bear case

    • KRRO's quarterly revenue changed -43.1% year over year.

    KRRO Earnings: Beat Rate and Next Report

    Korro Bio (KRRO) beat the EPS estimate in 7 of the last 8 quarters (87.5%). Its next report is expected on Mar 10, 2027.

    Beat rate
    7 of 8 quarters (87.5%)
    Average surprise
    15.0%
    EPS estimate (fiscal period ending Dec 31, 2026)
    -$1.38
    KRRO earnings history

    KRRO Earnings Date

    KRRO reports Mar 10, 2027. The date is estimated.

    Updated Nov 5, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology

    Frequently Asked Questions About KRRO

    When does KRRO report earnings?

    Korro Bio, Inc. (KRRO) is expected to report earnings on Mar 10, 2027.

    Does KRRO pay dividends?

    Korro Bio, Inc. (KRRO) does not currently pay a regular dividend.

    What is KRRO's market cap?

    Korro Bio, Inc. (KRRO) has a market capitalization of $186.81M with a current stock price of $12.71.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.